Your browser doesn't support javascript.
loading
Influence of the epiretinal membrane on ranibizumab therapy outcomes in patients with diabetic macular edema / Influência da membrana epirretiniana sobre os resultados da terapia de ranibizumab em edema macular diabético
Ercalik, Nimet Yesim; Imamoglu, Serhat; Kumral, Esra Turkseven; Yenerel, Nursal Melda; Bardak, Handan; Bardak, Yavuz.
Affiliation
  • Ercalik, Nimet Yesim; Haydarpasa Numune Training and Research Hospital. Ophthalmology Department. Istanbul. TR
  • Imamoglu, Serhat; Haydarpasa Numune Training and Research Hospital. Ophthalmology Department. Istanbul. TR
  • Kumral, Esra Turkseven; Haydarpasa Numune Training and Research Hospital. Ophthalmology Department. Istanbul. TR
  • Yenerel, Nursal Melda; Haydarpasa Numune Training and Research Hospital. Ophthalmology Department. Istanbul. TR
  • Bardak, Handan; Haydarpasa Numune Training and Research Hospital. Ophthalmology Department. Istanbul. TR
  • Bardak, Yavuz; Haydarpasa Numune Training and Research Hospital. Ophthalmology Department. Istanbul. TR
Arq. bras. oftalmol ; Arq. bras. oftalmol;79(6): 373-375, Nov.-Dec. 2016. tab
Article in En | LILACS | ID: biblio-838748
Responsible library: BR1.1
ABSTRACT
ABSTRACT

Purpose:

To investigate the influence of the epiretinal membrane (ERM) on intravitreal ranibizumab (IVR) therapy for diabetic macular edema (DME).

Methods:

This retrospective study included 56 eyes of 48 patients with DME divided into two groups the DME with ERM (study) and only DME (control) groups. Changes in the central macular thickness (CMT) and best-corrected visual acuity (BCVA) were evaluated.

Results:

In the study group, although the CMT was significantly reduced following the first injection (p<0.001), BCVA did not improve significantly (p=0.296). However, after the first injection, the control group exhibited both a significant decrease in CMT (p<0.001) and improvement in BCVA (p<0.001). However, the improvement in BCVA in the control group was not significantly different from the outcome of the study group.

Conclusions:

We observed a negative short-term influence of the ERM on IVR treatment for DME.
RESUMO
RESUMO

Objetivo:

Investigar a influência da membrana epirretiniana (ERM) na terapia intravítrea com ranibizumab (IVR) para o edema macular diabético (DME).

Métodos:

Este estudo retrospectivo consistiu de 56 olhos de 48 pacientes com DME que foram divididos em dois grupos o grupo DME com ERM (estudo) e o grupo só DME (controle). Foram avaliadas alterações na espessura central de macular (CMT) e melhor acuidade visual corrigida (BCVA).

Resultados:

No grupo de estudo, embora a CMT tenha sido significativamente reduzida após a 1ª injeção (p<0,001), a acuidade visual não melhorou significativamente (p=0,296). Após a 1ª injeção, o grupo controle apresentou diminuição significativa no CMT (p<0,001) e melhora na acuidade visual (p<0,001). No grupo controle, embora a mudança de CMT tenha sido significativa (p<0,001), a melhora da acuidade visual não foi significativa quando comparada com o grupo de estudo.

Conclusões:

No curto prazo, observou-se uma influência negativa da ERM sobre o IVR em DME.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: LILACS Main subject: Visual Acuity / Macular Edema / Epiretinal Membrane / Angiogenesis Inhibitors / Diabetic Retinopathy / Ranibizumab Type of study: Observational_studies Limits: Aged / Female / Humans / Male Language: En Journal: Arq. bras. oftalmol Journal subject: OFTALMOLOGIA Year: 2016 Document type: Article Affiliation country: Turkey Country of publication: Brazil

Full text: 1 Collection: 01-internacional Database: LILACS Main subject: Visual Acuity / Macular Edema / Epiretinal Membrane / Angiogenesis Inhibitors / Diabetic Retinopathy / Ranibizumab Type of study: Observational_studies Limits: Aged / Female / Humans / Male Language: En Journal: Arq. bras. oftalmol Journal subject: OFTALMOLOGIA Year: 2016 Document type: Article Affiliation country: Turkey Country of publication: Brazil